The influx of capital risk in Indian startups continues to remain depressed as the week did not include any big deals.
Total venture capital funding for the second week of September was $132 million– cutting through 39 offers. In comparison, the previous week saw a total funding of $199 million.
The absence of large venture-backed deals has contributed to this decline and it is unlikely that there will be a major upside any time soon. The only positive development during the week was the entry of online pharmacy start-up Tata 1mg into the unicorn club.
Given the macroeconomic situation – central banks around the world are raising interest rates, the war in Europe and the energy crisis, it is very unlikely that there will be a large influx of risk finance in India, and the only segment that will continue to see some activity will be early-stage startups.
E-pharmacy platform Tata 1MG raised $40 million from Tata Digital, MPOF Mauritius, HBM Healthcare and KWE Beteiligung at a valuation of $1.25 billion.
Akshayakalpa Organic, an organic dairy company, raised $15 million from British International Investment, Rainmatter Foundation and Venture Dairy.
Fintech start-ups GroMo raised $11 million from SIG Venture Capital, Y-Combinator, Das Capital, Goodwater Capital and Beyond Next Ventures.
B2B startup ZippMat raised $10 million from Matrix Partners India, Zephyr Peacock, HDFC Bank and TradeCred.
fintech startupcashflo raised $8.7 million from General Catalyst, Elevation Capital and other angel investors.
construction management companypower play raised $7.14 million from Accel, Sequoia Surge, India Quotient and the founders of Snapdeal.
Start-up Agritech Ayekart raised $5.5 million Caspian debt and Sily.
Luxury villa rental brandVista Stay raised over Rs 40 crore from DSG Consumer Partners, Capri Global and CA Holdings.